Dirk‐Jan Slebos

9.1k total citations · 1 hit paper
237 papers, 4.6k citations indexed

About

Dirk‐Jan Slebos is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Dirk‐Jan Slebos has authored 237 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 212 papers in Pulmonary and Respiratory Medicine, 39 papers in Physiology and 25 papers in Surgery. Recurrent topics in Dirk‐Jan Slebos's work include Chronic Obstructive Pulmonary Disease (COPD) Research (183 papers), Respiratory Support and Mechanisms (114 papers) and Pleural and Pulmonary Diseases (63 papers). Dirk‐Jan Slebos is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (183 papers), Respiratory Support and Mechanisms (114 papers) and Pleural and Pulmonary Diseases (63 papers). Dirk‐Jan Slebos collaborates with scholars based in Netherlands, United Kingdom and United States. Dirk‐Jan Slebos's co-authors include Karin Klooster, Felix Herth, Jorine E. Hartman, Nick H.T. ten Hacken, Pallav L. Shah, Huib A.M. Kerstjens, Arschang Valipour, Eva M. van Rikxoort, Henk F. Kauffman and Gerard H. Koëter and has published in prestigious journals such as New England Journal of Medicine, Nano Letters and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Dirk‐Jan Slebos

205 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation

2015 304 citations Karin Klooster, Nick H.T. ten Hacken et al. profile →

Peers

Countries citing papers authored by Dirk‐Jan Slebos

Since Specialization

Citations

This map shows the geographic impact of Dirk‐Jan Slebos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk‐Jan Slebos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk‐Jan Slebos more than expected).

Fields of papers citing papers by Dirk‐Jan Slebos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk‐Jan Slebos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk‐Jan Slebos. The network helps show where Dirk‐Jan Slebos may publish in the future.

Co-authorship network of co-authors of Dirk‐Jan Slebos

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk‐Jan Slebos. A scholar is included among the top collaborators of Dirk‐Jan Slebos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk‐Jan Slebos. Dirk‐Jan Slebos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of age, COPD severity, and cigarette smoke exposure on bronchial epithelial barrier function 2025 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·(unknown), Tillie‐Louise Hackett, Qing Chen, Chen Xi Yang, (unknown), (unknown), (unknown), Tessa Kole, Alen Faiz, (unknown), Dirk‐Jan Slebos, Karin Klooster, Wim Timens, Maarten van den Berge, Corry‐Anke Brandsma, Irene H. Heijink	5
2	Results From Airflow-3: Randomized, Double Blind, Sham Controlled Study of Targeted Lung Denervation in Patients With COPD 2025 ·American Journal of Respiratory and Critical Care Medicine ·G.J. Criner, Dirk‐Jan Slebos, Richard Sue, Surya P. Bhatt, (unknown), Charlie Strange, Bruno Degano, Nicolas Guibert, (unknown), Stephan Eisenmann, (unknown), Charles‐Hugo Marquette, (unknown), Frank C. Sciurba, Pallav L. Shah	0
3	Diaphragm Ultrasound and Surface Electromyography as Predictors of Clinical Deterioration in Acute Exacerbations of COPD: A Prospective Observational Study 2025 ·ERJ Open Research ·(unknown), (unknown), Eline Oppersma, Mireille A. Edens, Jan Willem van den Berg, Jos A. Stigt, Dirk‐Jan Slebos, Marieke L. Duiverman	0
4	Airway Scaffolds for Emphysema-related Hyperinflation: Six-Month Results from the BREATHE Trial 2025 ·American Journal of Respiratory and Critical Care Medicine ·Anand Tana, Arschang Valipour, Alvin Ing, Daniel Steinfort, Christopher M. Orton, Karin Klooster, (unknown), Jonathan Williamson, (unknown), Justin Garner, T. David Koster, (unknown), Marlies van Dijk, (unknown), Pallav L. Shah, Dirk‐Jan Slebos	1
5	Reference formulas for chest CT-derived lobar volumes in the lung-healthy general population 2024 ·European Radiology ·(unknown), (unknown), (unknown), Judith M. Vonk, Karin Klooster, Marleen de Bruijne, Maarten van den Berge, Dirk‐Jan Slebos, Rozemarijn Vliegenthart	0
6	Treatable traits in advanced emphysema patients eligible for bronchoscopic lung volume reduction with endobronchial valves 2024 ·Respiratory Medicine ·Rein Posthuma, (unknown), Jorine E. Hartman, Martijn A. Spruit, Dirk‐Jan Slebos, Lowie E.G.W. Vanfleteren, Anouk W. Vaes	3
7	Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valves 2024 ·Respiratory Medicine ·T. David Koster, Pallav L. Shah, Arschang Valipour, Gerard J. Criner, Felix Herth, Richard Sue, D. Kyle Hogarth, (unknown), (unknown), Raed Alalawi, Lisa Kopas, Avi J. Cohen, Douglas E. Wood, Jonathan S. Kurman, Narinder S. Shargill, Mark T. Dransfield, Dirk‐Jan Slebos, Michael Perch	2
8	Low-Dose CT–derived Bronchial Parameters in Individuals with Healthy Lungs 2024 ·Radiology ·(unknown), (unknown), Grigory Sidorenkov, (unknown), Jens Petersen, Dirk‐Jan Slebos, Geertruida H. de Bock, Maarten van den Berge, Marleen de Bruijne, Rozemarijn Vliegenthart	2
9	Defining a phenotype of severe COPD patients who develop chronic hypercapnia 2024 ·Respiratory Medicine ·(unknown), (unknown), Maaike de Vries, (unknown), Dirk‐Jan Slebos, Peter J. Wijkstra, Jorine E. Hartman, Marieke L. Duiverman	1
10	CT-based airway changes after smoking cessation in the general population 2024 ·European Journal of Radiology ·(unknown), Grigory Sidorenkov, Marcel van Tuinen, Dirk‐Jan Slebos, Geertruida H. de Bock, Maarten van den Berge, Marleen de Bruijne, Rozemarijn Vliegenthart	0
11	The impact of emphysema heterogeneity on treatment response after endobronchial valve treatment 2023 ·ERJ Open Research ·(unknown), Karin Klooster, Dirk‐Jan Slebos, Jorine E. Hartman	2
12	Host–device interactions: exposure of lung epithelial cells and fibroblasts to nickel, titanium, or nitinol affect proliferation, reactive oxygen species production, and cellular signaling 2023 ·Journal of Materials Science Materials in Medicine ·Simon D. Pouwels, Alina Sigaeva, (unknown), (unknown), (unknown), Jeroen Kuipers, Romana Schirhagl, Irene H. Heijink, Janette K. Burgess, Dirk‐Jan Slebos	5
13	Reduction of Lung Hyperinflation Improves Cardiac Preload, Contractility, and Output in Emphysema: A Clinical Trial in Patients Who Received Endobronchial Valves 2022 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Jorine E. Hartman, Lowie E.G.W. Vanfleteren, Huib A.M. Kerstjens, Joost P. van Melle, Tineke P. Willems, Dirk‐Jan Slebos	20
14	Determinants of Lung Fissure Completeness 2021 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Jorine E. Hartman, Cornelis J. Vermeulen, Maarten van den Berge, Alen Faiz, Huib A.M. Kerstjens, Jean‐Paul Charbonnier, Lowie E.G.W. Vanfleteren, Dirk‐Jan Slebos	6
15	Interventional Bronchoscopy 2020 ·American Journal of Respiratory and Critical Care Medicine ·Gerard J. Criner, Ralf Eberhardt, Sebastián Fernández-Bussy, Daniela Gompelmann, Fabien Maldonado, Neal M. Patel, Pallav L. Shah, Dirk‐Jan Slebos, Arschang Valipour, Momen M. Wahidi, Mark H. Weir, Felix Herth	67
16	Chartis Measurement of Collateral Ventilation: Conscious Sedation versus General Anesthesia – A Retrospective Comparison 2018 ·Respiration ·(unknown), Jorine E. Hartman, Nick H.T. ten Hacken, (unknown), Jean‐Paul Charbonnier, Eva M. van Rikxoort, Huib A.M. Kerstjens, Karin Klooster, Dirk‐Jan Slebos	9
17	Endobronchial Valves for Endoscopic Lung Volume Reduction: Best Practice Recommendations from Expert Panel on Endoscopic Lung Volume Reduction 2016 ·Respiration ·Dirk‐Jan Slebos, Pallav L. Shah, Felix Herth, Arschang Valipour	122
18	Bronchoscopic Lung Volume Reduction Coil Treatment of Severe Heterogeneous Emphysema 2010 ·CHEST Journal ·Dirk‐Jan Slebos, Armin Ernst, Stefan Blaas, Wolfgang Gesierich, Felix Herth	7
19	Longitudinal Profile of Bronchoalveolar Lavage Cell Characteristics in Patients with a Good Outcome after Lung Transplantation 2002 ·American Journal of Respiratory and Critical Care Medicine ·Dirk‐Jan Slebos, Janny Scholma, H. Marike Boezen, Gerard H. Koëter, Wim van der Bij, Dirkje S. Postma, Henk F. Kauffman	33
20	Eosinophilic Granulocytes and Interleukin-6 Level in Bronchoalveolar Lavage Fluid Are Associated with the Development of Obliterative Bronchiolitis after Lung Transplantation 2000 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Dirk‐Jan Slebos, H. Marike Boezen, Jan Willem van den Berg, Wim van der Bij, W.J. de Boer, Gerard H. Koëter, Wim Timens, Henk F. Kauffman, Dirkje S. Postma	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact